Skip to main content
BEAT
NASDAQ Industrial Applications And Services

HeartBeam Q2 2026: $5.0M Net Loss, Going Concern Warning, and $11.5M Raise

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.597
Mkt Cap
$32.738M
52W Low
$0.481
52W High
$4
52W Position info
24% above low
Off High info
85% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BEAT sits 24% above its 52-week low of $0.481.

Summary

HeartBeam's Q2 2026 filing shows a $5.0 million net loss, $8.7 million in cash, and a going concern warning. The company raised $11.5 million in April but still lacks sufficient liquidity for the next 12 months.


Key Events · Earnings and Guidance · BEAT

  • Going Concern Warning Reiterated

    Management states existing liquidity is insufficient to fund operations for the next twelve months, raising substantial doubt about the company's ability to continue as a going concern.

  • Q2 2026 Net Loss of $5.0M

    Net loss for the three months ended June 30, 2026 was $5.0 million, compared to $5.0 million in the prior year period. Cash and cash equivalents totaled $8.7 million as of June 30, 2026.

  • $11.5M Underwritten Offering Completed

    The company sold 14,375,000 shares for gross proceeds of $11.5 million in April 2026, with insiders purchasing $1.0 million. Net proceeds were approximately $10.3 million.

  • Nasdaq Deficiency Deadline Looms

    The stock trades at $0.5972, below the $1.00 minimum bid requirement. The company has until December 29, 2026 to regain compliance or face delisting.


Analysis · BEAT · Industrial Applications And Services

HeartBeam's Q2 2026 report confirms the company has only $8.7 million in cash and reiterates that existing liquidity is insufficient to fund operations for the next twelve months, raising substantial doubt about its ability to continue as a going concern. The company completed an $11.5 million underwritten offering in April 2026, with insiders purchasing $1.0 million, but the cash runway remains tight. The report also details a $2.2 million performance-based RSU grant to President Branislav Vajdic and subsequent RSU grants to officers, adding to dilution. With the stock trading at $0.5972, below the Nasdaq $1.00 minimum bid requirement, the company faces a December 29, 2026 deadline to regain compliance or risk delisting.

At the time of this filing, BEAT was trading at $0.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $32.7M. The 52-week trading range was $0.48 to $4.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BEAT - Latest Insights

BEAT
Aug 05, 2026, 6:16 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $0.4998
Real-time Price: $0.5972 info
Change: +$0.0974 (+19%) info
Market Cap: $32.738M info
BEAT
Aug 03, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4899
Real-time Price: $0.5972 info
Change: +$0.1073 (+22%) info
Market Cap: $32.738M info
BEAT
Jul 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.720
Real-time Price: $0.5972 info
Change: -$0.1228 (-17%) info
Market Cap: $32.738M info
BEAT
Jun 24, 2026, 5:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.698
Real-time Price: $0.5972 info
Change: -$0.1008 (-14%) info
Market Cap: $32.738M info
BEAT
Jun 24, 2026, 4:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.692601
Real-time Price: $0.5972 info
Change: -$0.095401 (-14%) info
Market Cap: $32.738M info